Össur Hf: Q1 Results 2017
(Thomson Reuters ONE) -
Announcement from Össur hf. No. 33/2017
Reykjavík, 27 April 2017
ÖSSUR Q1 RESULTS 2017
Highlights Q1 2017
* Sales amounted to USD 131 million compared to USD 114 million in Q1 2016,
corresponding to 17% growth and 7% organic, both measured in local currency.
* Gross profit amounted to USD 82 million and 62% of sales, compared to USD
71 million and 63% of sales in Q1 2016.
* EBITDA amounted to USD 20 million or 16% of sales, compared to USD 19
million or 16% of sales in Q1 2016, corresponding to a 26% growth measured
in local currency. Underlying operational margin improvements were
neutralized by negative impact from changes in foreign exchange rates and
temporary negative impact from acquisitions.
* Net profit grew by 13% in USD terms and amounted to USD 10 million or 8% of
sales, compared to USD 9 million or 8% of sales in Q1 2016.
* Cash generated by operations amounted to USD 10 million or 7% of sales,
compared to USD 16 million or 14% of sales in Q1 2016.
* Dividends of DKK 0.12 per share, corresponding to approximately 15% of the
Company's net profit in 2016, were paid at the end of March 2017.
* Registration of the share capital reduction of 5,837,832 shares with a
nominal value of ISK 1 each was completed on 11 April 2017. The shares were
removed from trading on Nasdaq Copenhagen on 19 April 2017 and the total
share capital is afterwards ISK 437,162,725.
* Össur acquired 6,689,988 of own shares in Q1 2017 for approximately USD 25
million.
Financial Guidance for 2017
The financial guidance for the full year of 2017 is unchanged:
* Sales growth LCY in the range of 7-8%
* Organic sales growth LCY in the range of 4-5%
* EBITDA margin before special items in the range of 19-20% of sales
* Capital expenditures around 4% of net sales
* Effective tax rate around 26%
Jon Sigurdsson, President & CEO, comments:
"We are pleased to deliver a quarter with solid organic sales growth and stable
profitability, bearing in mind that the first quarter of the year is seasonally
our weakest. EMEA and APAC had strong growth in both business segments during
the quarter and we saw good performance in our prosthetics business in the
Americas. Our high-end innovative products are driving growth on a global level.
Integration of our recently acquired companies, Touch Bionics and Medi
Prosthetics, is going as planned and we are excited to realize their potential."
Conference Call
Össur will host a conference call on Friday 28 April 2017 at 9:00 CET/ 7:00
GMT/ 3:00 EDT.
To participate in the call please dial: Europe: + 45 3544 5580, +44 (0)
203 364 5374 or +46 (0) 8 505 564 74,
The United States: + 1 855 753 2230, Iceland: +354 800 7417. A webcast can be
followed on the Össur website: www.ossur.com/investors
Company announcement Össur hf 31.3.2017:
http://hugin.info/133773/R/2099612/795889.pdf
2017 Q1 Investor Presentation:
http://hugin.info/133773/R/2099612/795891.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ossur Hf via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 27.04.2017 - 22:00 Uhr
Sprache: Deutsch
News-ID 538984
Anzahl Zeichen: 3825
contact information:
Town:
Reykjavik
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 173 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Össur Hf: Q1 Results 2017"
steht unter der journalistisch-redaktionellen Verantwortung von
Ossur Hf (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
